Analyst Ratings for Eloxx Pharma (ELOX)
ELOX Rating Summary
ELOX Price Target Summary
- Highest: $43.00 (Guggenheim)
- Lowest: $40.00 (LifeSci Capital)
- Average: $41.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$41.50 (+242.7%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$41.50 (+242.7%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/22/2026 | LifeSci Capital | Rami Katkhuda | New Coverage | Outperform (N/A) |
40.00 (N/A) |
12.00 (12.11) |
0.92% | Details |
| 7/20/2026 | Guggenheim | Vamil Divan | New Coverage | Buy (N/A) |
43.00 (N/A) |
12.02 (12.11) |
0.75% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
